PJP vs. IYH: Which Healthcare ETF Is the Better Buy?

The iShares U.S. Healthcare ETF (IYH) offers a broader portfolio with a lower expense ratio than the Invesco Pharmaceuticals ETF (PJP). PJP has delivered significantly higher total returns over the past year.

The Motley Fool • Jul 20, 2026

Which is the Better Choice for Healthcare Investors? IYH or BBH?

iShares U.S. Healthcare ETF provides broader exposure with 100 holdings compared to the 25 found in VanEck Biotech ETF VanEck Biotech ETF has delivered higher recent total returns but carries significantly greater historical price volatility iShares U.S. Healthcare ETF offers a higher dividend yield and lower five-year maximum drawdown for income-focused investors

The Motley Fool • Jul 11, 2026

Anxious About an AI Bubble? ETFs to Help Navigate the Risk

Stretched tech valuations are reviving AI bubble fears. These ETFs can help navigate the uncertainty.

Zacks Investment Research • Jun 30, 2026

Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It

Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and higher dosing—effectively extends product lifecycles and drives shareholder value.

Seeking Alpha • Jun 29, 2026

Should You Invest in the iShares U.S. Healthcare ETF (IYH)?

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the iShares U.S. Healthcare ETF (IYH), a passively managed exchange traded fund launched on June 12, 2000.

Zacks Investment Research • Jun 24, 2026

Market-Weighted Healthcare or Active Manager Selection? IYH vs. PINK

Simplify Health Care ETF carries a higher expense ratio but has significantly outperformed iShares U.S. Healthcare ETF over the past year iShares U.S. Healthcare ETF offers a higher dividend yield and lower price volatility as measured by its lower historical beta The Simplify fund follows an active mission-driven strategy targeting innovation while the iShares fund provides passive exposure to 102 healthcare stocks

The Motley Fool • Jun 19, 2026

FHLC vs. IYH: Which Healthcare ETF Is the Better Buy in 2026?

Fidelity MSCI Health Care Index ETF (FHLC) offers a lower expense ratio and higher dividend than the iShares U.S. Healthcare ETF (IYH). IYH maintains a more concentrated portfolio, with 101 holdings compared to FHLC's 338 positions.

The Motley Fool • Jun 16, 2026

Health Care ETFs: XLV Delivers Low Fees and Solid Returns

The State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to 0.38% for the iShares U.S. Healthcare ETF The State Street Health Care Select Sector SPDR ETF provides a higher trailing-12-month dividend yield of 1.70% while the iShares U.S. Healthcare ETF offers 1.20% The iShares U.S. Healthcare ETF holds 102 stocks while the State Street Health Care Select Sector SPDR ETF concentrates on 60 large-cap names

The Motley Fool • Jun 16, 2026

ETFs That May Provide Investors Protection From Market Risks

Geopolitical tensions and tech weakness are fueling volatility in U.S. markets. Explore ETFs for portfolio stability.

Zacks Investment Research • Jun 10, 2026

Too Much Tech in Your Portfolio? ETFs to Help You Diversify

The recent rotation out of AI-linked stocks highlights the risks of a narrow market rally. As concentration risk rises, defensive ETFs could help investors build more resilient portfolios.

Zacks Investment Research • Jun 5, 2026